Tanaka Yuko 田中裕子

… Alternative Names

田中裕子タナカユウコ

TANAKA Yuko 田中裕子

Less

Researcher Number	70449130
Affiliation (Current)	2025: 東京医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2022 – 2023: 東京医科大学, 医学部, 講師 2012 – 2013: 東京医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Clinical oncology
Keywords	Principal Investigator 多発性骨髄腫 / MCT / 髄外形質細胞腫 / 腫瘍免疫 / 乳酸シャトル / 腫瘤形成骨髄腫 / multiple　myeloma / sphingosine1phosphate / ABC294640 / sphingosine 1-phasphate / fingolimod / sphingosine-1 phosphate / multile myeloma

代謝を介した腫瘍免疫機構の解析に基づいた骨髄腫予後因子同定と治療層別化の探索Principal Investigator
- Principal Investigator
  
  田中裕子
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tokyo Medical University
Bioactive ripid ;Concened with MMPrincipal Investigator
- Principal Investigator
  
  TANAKA Yuko
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Clinical oncology
- Research Institution
  Tokyo Medical University

All 2023 2022 2021 2014 2013

All Journal Article Presentation

[Journal Article] WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment.2023
- Author(s)
  Okabe S, Tanaka Y, Moriyama M, Gotoh A.
- Journal Title
  
  Cancer Cell Int.
  
  Volume: 23 Issue: 1 Pages: 128-128
- DOI
  10.1186/s12935-023-02961-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07644, KAKENHI-PROJECT-22K07242
[Journal Article] Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions2022
- Author(s)
  Okabe Seiichi、Tanaka Yuko、Gotoh Akihiko
- Journal Title
  
  Biomarker Research
  
  Volume: 10 Issue: 1 Pages: 31-31
- DOI
  10.1186/s40364-022-00376-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07242
[Journal Article] Potential of a sphingosine 1 phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment2022
- Author(s)
  Tanaka Yuko、Okabe Seiichi、Ohyashiki Kazuma、Gotoh Akihiko
- Journal Title
  
  Oncology Letters
  
  Volume: 23 Issue: 4 Pages: 111-111
- DOI
  10.3892/ol.2022.13231
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07242
[Journal Article] Effect of D-mannose on Philadelphia chromosome-positive leukemia cells2021
- Author(s)
  Okabe Seiichi、Tanaka Yuko、Gotoh Akihiko
- Journal Title
  
  Cancer Biomarkers
  
  Volume: - Issue: 3 Pages: 1-10
- DOI
  10.3233/cbm-210141
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06690, KAKENHI-PROJECT-22K07242
[Journal Article] Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation.2014
- Author(s)
  Okabe S, Tauchi T, Tanaka Y, Kitahara T, Kimura S, Maekawa T, Ohyashiki K
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 15 Issue: 2 Pages: 207-215
- DOI
  10.4161/cbt.26725
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24390244, KAKENHI-PROJECT-24659461, KAKENHI-PROJECT-24701036, KAKENHI-PUBLICLY-25112706, KAKENHI-PROJECT-25461425
[Journal Article] Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia.2014
- Author(s)
  Okabe S, Tauchi T, Kimura S, Maekawa T, Kitahara T, Tanaka Y, Ohyashiki K
- Journal Title
  
  Plos One
  
  Volume: 9(2) Issue: 2 Pages: e89080-e89080
- DOI
  10.1371/journal.pone.0089080
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390244, KAKENHI-PROJECT-24701036, KAKENHI-PROJECT-25461425
[Journal Article] Activity of omacetaxine mepesuccinate against ponatinib-resistant BCR-ABL-positive cells2013
- Author(s)
  Okabe S, Tauchi T, Tanaka Y, Katagiri S,Kitahara T, Ohyashiki K.
- Journal Title
  
  Blood
  
  Volume: 122(17) Issue: 17 Pages: 3086-8
- DOI
  10.1182/blood-2013-04-494773
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24701036
[Journal Article] Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL expressing leukemic cells.2013
- Author(s)
  Okabe S
- Journal Title
  
  Cancer Cell International
  
  Volume: 13(1) Issue: 1 Pages: 32-40
- DOI
  10.1186/1475-2867-13-32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390244, KAKENHI-PROJECT-24659461, KAKENHI-PROJECT-24701036, KAKENHI-PUBLICLY-25112706, KAKENHI-PROJECT-25461425, KAKENHI-PUBLICLY-23112507
[Journal Article] Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells2013
- Author(s)
  Okabe S, Tauchi T, Tanaka Y, Ohyashiki K.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 435(3) Issue: 3 Pages: 506-11
- DOI
  10.1016/j.bbrc.2013.05.022
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24701036
[Presentation] 濾胞性リンパ腫患者のCOVID-19罹患状況に関する当施設における後方視的解析2023
- Author(s)
  田中裕子
- Organizer
  第85回日本血液学会学術増改
- Data Source
  KAKENHI-PROJECT-22K07242
[Presentation] Serum sphingosine-1 phospate is possible to be an available biomarker for multiple myeloma2013
- Author(s)
  田中裕子、岡部聖一、伊藤良和、田内哲三、大屋敷一馬
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  ロイトン札幌(札幌市)
- Year and Date
  2013-10-11
- Data Source
  KAKENHI-PROJECT-24701036
[Presentation] Serum sphingosine-1-phosphate is possible to be an available biomarker for multiple myeloma2013
- Author(s)
  Tanaka Y, Okabe S, Ohyashiki K
- Organizer
  第75回日本血液学会総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24701036
[Presentation] Therapeutic potential of targeting sphingosine-1-phosuphate and sphingosine kinases in multiple myeloma2013
- Author(s)
  Tanaka Y, Okabe S, Ohyashiki K
- Organizer
  第55回米国血液学会総会
- Place of Presentation
  ニューオリンズ
- Data Source
  KAKENHI-PROJECT-24701036
[Presentation] Therapeutic Potential of Targeting Sphingosine-1 Phosphate and Sphingosine Kinases in Multiple Myeloma Cells2013
- Author(s)
  Yuko Tanaka,Seiichi Okabe, Tetsuzo Tauchi
- Organizer
  第55回アメリカ血液学会総会
- Place of Presentation
  New Orleans
- Year and Date
  2013-12-13
- Data Source
  KAKENHI-PROJECT-24701036

1. 前川平

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 後藤明彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 岡部聖一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tanaka Yuko 田中 裕子

田中 裕子 タナカ ユウコ

TANAKA Yuko 田中 裕子

Research Projects

Research Products

Co-Researchers

代謝を介した腫瘍免疫機構の解析に基づいた骨髄腫予後因子同定と治療層別化の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Bioactive ripid ;Concened with MMPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential of a sphingosine 1 phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of D-mannose on Philadelphia chromosome-positive leukemia cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Activity of omacetaxine mepesuccinate against ponatinib-resistant BCR-ABL-positive cells2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL expressing leukemic cells.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells2013

Author(s)

Journal Title

DOI

Data Source

[Presentation] 濾胞性リンパ腫患者のCOVID-19罹患状況に関する当施設における後方視的解析2023

Author(s)

Organizer

Data Source

[Presentation] Serum sphingosine-1 phospate is possible to be an available biomarker for multiple myeloma2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Serum sphingosine-1-phosphate is possible to be an available biomarker for multiple myeloma2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Therapeutic potential of targeting sphingosine-1-phosuphate and sphingosine kinases in multiple myeloma2013

Author(s)

Tanaka Yuko 田中裕子

田中裕子タナカユウコ

TANAKA Yuko 田中裕子